A2M-FAR1 Fusion FISH Probe
The A2M-FAR1 Fusion FISH Probe is used to confirm a fusion of the A2M and FAR1 genes. The fusion of the A2M and FAR1 genes has been associated with Kidney Renal Clear Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| A2M-FAR1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| A2M-FAR1-20-AQAQ | 20 (40 μL) | 200 μL |
|
A2M Gene Summary
The protein encoded by this gene is a protease inhibitor and cytokine transporter. It uses a bait-and-trap mechanism to inhibit a broad spectrum of proteases, including trypsin, thrombin and collagenase. It can also inhibit inflammatory cytokines, and it thus disrupts inflammatory cascades. Mutations in this gene are a cause of alpha-2-macroglobulin deficiency. This gene is implicated in Alzheimer's disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits. A related pseudogene, which is also located on the p arm of chromosome 12, has been identified. [provided by RefSeq, Nov 2016]
Gene Name: Alpha-2-macroglobulin
Chromosome: CHR12: 9220303 -9268558
Locus: 12p13.31
FAR1 Gene Summary
The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015]
Gene Name: Fatty Acyl-CoA Reductase 1
Chromosome: CHR11: 13690205 -13753893
Locus: 11p15.3
Gene Diseases
The A2M FAR1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Kidney Renal Clear Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|